Mark Marzinke
0000-0003-1670-8786
3 papers found
Refreshing results…
Limited Evidence for Use of a Black Race Modifier in eGFR Calculations: A Systematic Review
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc
Missing publications? Search for publications with a matching author name.